Navigation Links
Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation

CLEVELAND, Ohio, June 30, 2010 /PRNewswire/ -- Simbionix Ltd., a subsidiary of Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, and USF Health, an organization dedicated to creating a model of health care based on understanding the full spectrum of health, are proud to announce that together they received a BIRD (Binational Industrial Research and Development) Grant to support the development of a Laparoscopic Hysterectomy simulation module.

The BIRD Foundation was established by the U.S. and Israeli governments in 1977 to generate mutually beneficial cooperation between the private sectors of the U.S. and Israeli high tech industries, including start-ups and established organizations. BIRD provides both matchmaking services between U.S. and Israeli companies, as well as funding covering up to 50 percent of project development and initial product commercialization costs.

Developing this new Laparoscopic Hysterectomy module supports Simbionix' goal for including complex advanced procedures in their comprehensive LAP Mentor(TM) Simulator. It also reaffirms Simbionix' commitment towards improving the quality of care in the field of Women's Health. Approximately 600,000 hysterectomies are performed annually in the US, making it the second most frequently performed major surgical procedure. The Laparoscopic Hysterectomy procedure requires greater surgical skills than the vaginal and abdominal methods, and as such necessitates performing approximately 15 procedures before surgeons become proficient. Since this procedure is difficult to teach using conventional methods, practicing Ob-Gyns may have never received laparoscopic training during their residency. The new module will use medical simulation teaching methods to provide the necessary complex skills acquisition and training for surgeons.

Dr. Stephen K. Klasko, CEO of USF Health and Dean of the USF College of Medicine stated: "As simulation technology expands its use as a driver for quality and safety in medicine, it will take great organizations working together. At USF Health, we have been a leader in applying technology to improve the health of our community. Over the past year, USF Health has had the opportunity to work with Simbionix, the world's leading provider of medical education and simulation products to deliver training for medical students, residents, practicing physicians and other healthcare professionals to enhance technical competence and improve patient outcomes. The award of the BIRD grant provides a fantastic opportunity for us to work with Simbionix to develop the first laparoscopic hysterectomy simulation module for training GYN surgeons in minimally invasive surgery techniques. This project has the potential to have a huge impact on the quality of practice of gynecologists worldwide. Through us working together, our doctors, our patients and the health of our communities will stand to be the winners."

"Simbionix makes it a priority to cooperate with the medical community on a regular basis for the advancement of medical education and training" says Simbionix President Ran Bronstein. "We are honored to have received this grant and to be working on this exciting project in conjunction with USF. Simbionix' unique, advanced simulation technology, combined with the clinical and educational expertise of USF Health's collaborating physicians, and USF Health's experience in integrating medical simulation into certifiable curricula, will ensure that the advanced GYN - Hysterectomy simulation module will truly be an innovative and critical contribution to improving women's healthcare."

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit

About USF Health

USF Health ( is dedicated to creating a model of health care based on understanding the full spectrum of health. It includes the University of South Florida's colleges of medicine, nursing, and public health; the schools of biomedical sciences as well as physical therapy & rehabilitation sciences; and the USF Physicians Group. With more than $380.4 million in research grants and contracts last year, the University of South Florida is one of the nation's top 63 public research universities and one of only 25 public research universities nationwide with very high research activity that is designated as community-engaged by the Carnegie Foundation for the Advancement of Teaching.

    Rebecca Zitter
    Manager of Marketing Communications and Distributor Relations

SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. AMS Receives 510(k) Clearance of Its Revolutionary MoXy(TM) Liquid Cooled Fiber for Fast, Safe Treatment of Enlarged Prostate
5. Mylan Receives Approval for Generic Version of Arimidex® Tablets
6. Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
7. Solta Medical Announces Thermage CPT™ and Fraxel re:store® Dual Systems Receive Health Canada Approval
8. Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
9. Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
10. PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects
11. Mylan Receives Approval for Generic Version of Zocor® Tablets
Post Your Comments:
(Date:11/25/2015)... 25, 2015 --> ... eine Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, ... ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... Leben gerufenen und von Edelris gemeinsam mit seinen Partnern ... Behandlungsziel für HBV identifiziert, und es wurden neue Inhaltsstoffe ...
(Date:11/24/2015)... 24, 2015  Natera, Inc. (Nasdaq: ... testing and the analysis of circulating cell-free ... at the 27 th  Annual Piper Jaffray ... p.m. ET.  Matthew Rabinowitz, Ph.D., CEO of Natera, ... activities and financial outlook.  ...
(Date:11/24/2015)... York , 24. November 2015 /PRNewswire/ ... Avery Breathing Pacemaker Systems, ist erfreut, die ... Clinical Consultant bekannt geben zu können. ...   --> Foto - ... (Schweden). Von 1984-1986 war er ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch ... solutions involving adult stem cell therapies to patients with chronic degenerative medical conditions. ... as a Registered Trademark (RTM). , Organizations are required to hold a registered ...
(Date:11/24/2015)... ... ... Dr. Todd S. Afferica, a noted general dentist in Norcross, GA , ... now uses the BIOLASE WaterLase iPlus 2.0™ in many of his dental procedures. This ... cutting tools, such as the scalpel and high-speed drill, which can both cause patients ...
(Date:11/24/2015)... Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... explored the different restrictions and variables that determine which patients are or are not ... those patients that have a BMI over 40, are more than 100 pounds overweight, ...
(Date:11/24/2015)... City, UT (PRWEB) , ... November 24, 2015 , ... ... Forbes Magazine. For a business, it is critical that the first impression be positive ... business, they are not likely to buy anything or want to return. They will ...
Breaking Medicine News(10 mins):